Ilenia Calcaterra: Clinical Relevance of Persistent Pain in Emicizumab-Treated Haemophilia A
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work during the free paper session at the WFH 2026 World Congress in Kuala Lumpur.
In this study, we explored the multidimensional pain experience of adults with severe haemophilia
A receiving Emicizumab prophylaxis using the Multidimensional Haemophilia Pain Questionnaire (MHPQ).
Our findings highlight an important clinical message: even in the era of highly effective bleed prevention, pain remains prevalent and functionally relevant, suggesting that haemophilia-related pain is not exclusively bleeding-driven and deserves structured, multidimensional assessment in routine care.
Grateful for the opportunity to share our data, for the stimulating scientific discussion, and for the chance to contribute to ongoing research aimed at improving the lives of people with haemophilia.”
Other posts featuring Ilenia Calcaterra on Hemostasis Today.
-
May 15, 2026, 15:19Tareq Abadl: Did You Know One Blood Donation Can Be Divided Into Tiny ‘Baby-Sized’ Transfusions?
-
May 15, 2026, 15:15ISBT: The Universal Language of Safe Blood Transfusion – Ali AlBahar
-
May 15, 2026, 14:11Megan Adediran: Maternal Experiences in the Management of Pediatric Bleeding Disorders
-
May 15, 2026, 14:10Mostafa Faisal Mohammed Saleh: Managing Severe Aplastic Anemia in Pregnancy After allo-HSCT
-
May 15, 2026, 14:06Kabir Olaniran: The Hidden Kidney Risk Behind the Sickle Cell Gene
-
May 15, 2026, 13:46Mohammud Ibraheem: Pregnancy Associated Stroke and the Hypercoagulable State
-
May 15, 2026, 13:45Rana Mohamed: Pediatric and Adult Patterns of Spontaneous Intracerebral Hemorrhage
-
May 15, 2026, 13:45Colin Evans: Vascular Discovery in American Heart Association AVTB
-
May 15, 2026, 13:44Chan Man Nok: Nanorobotic Innovation in Atherosclerotic Plaque Removal